Anastrozole is an aromatase inhibitor used to treat breast cancer in postmenopausal women. It works by blocking the aromatase enzyme, which is responsible for estrogen production, thereby slowing the growth of hormone-sensitive tumors. Anastrozole's clinical relevance lies in its effectiveness in reducing the risk of cancer recurrence and improving survival rates. In summary, Anastrozole is a vital treatment option for managing hormone-dependent breast cancer.
Anastrozole inhibits the aromatase enzyme, reducing estrogen levels and thereby limiting the growth of estrogen-dependent tumors.